A Phase 1, Open-label, Randomised, Crossover Study to Determine the Comparative Bioavailability of 20 mg Lomitapide Where the Contents Have Been Opened and Sprinkled in Applesauce or Mashed Banana ('Sprinkled Contents') to a Single Oral Capsule Dose of 20 mg Lomitapide ('Intact Capsule') in Healthy Subjects
Latest Information Update: 14 Jan 2020
At a glance
- Drugs Lomitapide (Primary)
- Indications Hyperlipoproteinaemia type IIa
- Focus Pharmacokinetics
- Sponsors Aegerion Pharmaceuticals
- 03 Feb 2014 New trial record